Special Reports
Slippery Slope
More in Slippery Slope
In another edition of the Slippery Slope series examining use of surrogate endpoints in drug approvals, 51˶ and the Milwaukee Journal Sentinel find diet drugs are approved without solid evidence of benefits, but with hints of harm.
Apr 19, 2015
Makers of diet drugs spent more than $60 million on payments to doctors, organized medicine, and lobbyists to get their drugs approved.
Apr 19, 2015